Cyclic peptideantibiotics Cyclic peptide drugs represent a rapidly evolving class of pharmaceuticals, drawing inspiration from nature's own molecular designs to address challenging disease targets. These molecules, characterized by a closed loop of amino acids, offer distinct advantages over traditional small molecules and linear peptides, including enhanced stability, improved binding affinity, and greater specificity. As an established and growing area of drug development, cyclic peptides are increasingly being explored for their therapeutic potential across a wide range of conditions, from bacterial infections to cancer and inflammatory diseases.
The inherent stability of cyclic peptides, stemming from their constrained structure, makes them particularly attractive for therapeutic applications. Unlike linear peptides, which are more susceptible to enzymatic degradation, the cyclic nature of these molecules typically confers greater resistance to proteases. This enhanced metabolic stability can lead to improved pharmacokinetic profiles, allowing for longer circulation times and potentially reduced dosing frequency作者:S You·2024·被引用次数:28—Cyclic peptides are an established class of pharmaceuticals, with the ability to bind to a broader range of protein targets than traditional small molecules .... Furthermore, their three-dimensional structure allows them to interact with a broader spectrum of biological targets, including those previously considered "undruggable" by conventional small-molecule approaches.作者:L Yang·2025·被引用次数:3—cyclicpeptideis a Python package for cyclic peptide drug design that aims to streamline the integration of cyclic peptides into modern drug discovery ... This versatility positions cyclic peptides as a powerful instrument for advancing drug discovery efforts.
A significant number of cyclic peptide drugs have achieved clinical approval, underscoring their therapeutic value. Over the past two decades, there has been a steady increase in the number of approved cyclic peptide therapeutics, with some estimates suggesting more than 40 currently in clinical useCyclic peptide therapeutics: past, present and future. These approved agents span various therapeutic areas.2025年8月18日—Cyclic peptides are promising therapeutic agentsfor challenging targets, especially protein–protein interactions. For instance, hormones and hormone analogues like oxytocin, octreotide, and vasopressin, alongside antibiotics such as vancomycin, exemplify the established role of cyclic peptides.Cyclic Peptide Screening Methods for Preclinical Drug ... More recent developments highlight their application in treating bacterial infections and their potential in managing inflammatory cascades, as seen in agents designed to prevent sepsis-induced organ dysfunctionCyclic peptidesgenerally exhibit enhanced metabolic stability, cell permeability, and binding affinity to biological targets compared to linear peptide .... The ongoing research and development pipeline indicates a continued expansion of cyclic peptide applications.2天前—A novel long-acting C5a-blocking cyclic peptideprevents sepsis-induced organ dysfunctionvia effective blockade of the inflammatory cascade.
The development of cyclic peptide drugs often begins with inspiration from natural products, which are abundant sources of these fascinating moleculesCyclic Peptides as Drugs for Intracellular Targets: The Next .... Historically, many cyclic peptide drugs were discovered through isolation from natural sources. However, contemporary drug discovery efforts increasingly rely on de novo design and synthesis. This involves engineering peptides with specific sequences and structures to achieve desired binding affinities and pharmacological properties. Advances in synthetic methodologies and computational tools have streamlined the process of designing cyclic peptides that can bind challenging disease targets with high affinity and specificity. Furthermore, chemical modifications play a crucial role in translating these peptides into drug-like molecules suitable for clinical use, optimizing aspects like cell permeability and bioavailability.
The future of cyclic peptide drugs appears exceptionally promisingCyclic peptides. Their capacity to target complex protein-protein interactions and intracellular targets is a key area of ongoing research. The development of cell-permeable cyclic peptides that can effectively reach intracellular targets represents a significant frontier, opening doors for treating diseases that were previously inaccessible to peptide therapeuticsCyclic peptide therapeutics. (a) Cyclic peptide drugs .... Innovations in formulation and delivery are also crucial, with efforts underway to develop oral peptide formulations, moving beyond traditional injectable routes.Cyclic Peptides for Drug Development - Ji - 2024 As synthetic biology and computational drug design continue to advance, the identification and optimization of novel cyclic peptide drug leads are expected to accelerate, solidifying their position as a cornerstone of future pharmaceutical innovation.
Join the newsletter to receive news, updates, new products and freebies in your inbox.